神经浸润对1801例胃癌术后预后的影响

Effect of perineural invasion in prognosis of 1801 patients undergoing radical resection of gastric cancer

  • 摘要: 目的:探讨神经浸润与胃癌临床病理因素及预后的关系。
    方法:采用回顾性病例对照研究方法。收集1999年3月至2015年11月福建医科大学附属肿瘤医院收治的1 801例胃癌患者的临床病理资料。患者行手术治疗以尽可能达到根治性切除目的,切除全胃或2/3以上胃及D2淋巴结清扫术。术前临床分期为Ⅲ期患者接受新辅助化疗。术后病理学分期为T3~T4期、淋巴结阳性的T1~T2期,以及具有高危因素(肿瘤低分化、脉管浸润、神经浸润、年龄<50岁)的T2N0期患者予以术后化疗。观察指标:(1)治疗情况。(2)病理学特征。(3)随访结果。(4)影响患者预后的因素。通过门诊、电话进行随访。术后第 1个月随访;术后2年内每3个月随访1次;术后3~5年,每6个月随访1次;随访项目包括问诊、体格检查、血常规、生化检查、CEA、CA199、彩色多普勒超声或CT、内镜检查等。随访时间截至2016年2月。正态分布的计量资料采用±s表示,组间比较采用t检验;偏态分布的计量资料采用M(范围)表示。等级资料比较采用非参数检验。单因素和多因素分析采用COX回归模型,并计算HR和95%可信区间。采用 KaplanMeier法绘制生存曲线,Logrank检验进行生存分析。
    结果:(1)治疗情况:1 801例胃癌患者均行传统开腹手术,其中1 570例行根治性手术,231例行姑息性手术。1 029例患者行全胃切除术,540例行远端胃切除术,201例行扩大切除术,31例行残胃切除术。1 801例患者手术时间为(173±40)min,术中出血量为(224±91)mL,清扫淋巴结数目为(30±13)枚,术后住院时间为(15±9)d。1 801例胃癌患者中,79例行术前新辅助化疗,906例行术后辅助化疗。(2)病理学特征:1 801例胃癌患者术后病理学检查结果显示: 509例神经浸润阳性,1 292例神经浸润阴性。神经浸润阳性胃癌患者的肿瘤位置上区、中区、下区、全胃、残胃分别为173、189、123、12、12例,Borrmann分型Ⅰ型、Ⅱ型、Ⅲ型、Ⅳ型分别为13、213、244、39例,分化程度较好和较差分别为172、337例,肿瘤直径<5 cm和≥5 cm分别为244、265例,病理学分期Ⅰ、Ⅱ、Ⅲ、Ⅳ期分别为27、54、346、82例,浸润深度T1、T2、T3、T4期分别为17、24、26、442例,淋巴结转移N0、N1、N2、N3期分别为77、84、109、239例,脉管癌栓阳性和阴性分别为383、126例;神经浸润阴性胃癌患者分别为395、417、428、29、23例,92、511、629、60例,536、756例,833、459例,263、283、623、123例,188、169、289、646例,409、219、312、352例,437、855例;两者上述指标比较,差异均有统计学意义(x2=14.142,Z=-2.098, x2=9.061,41.536,Z=-10.389,-13.824,-8.638, x2=252.624,P<0.05)。(3)随访结果:1 629例患者获得随访,随访时间为1.0~99.0个月,中位随访时间为37.3个月。患者5年总体生存率为58.5%。(4)影响患者预后的因素:单因素分析结果显示:肿瘤位置、Borrmann分型、分化程度、肿瘤直径、病理学分期、浸润深度、淋巴结转移、脉管癌栓、神经浸润是影响胃癌患者预后的因素(HR=1.209,1.303,1.496,2.303,3.368,2.057,1.812,2.013,1.332,95%可信区间:1.123~1.301,1.171~1.449,1.290~1.736,2.001~2.649,3.012~3.767,1.856~2.279,1.694~1.939,1.749~2.317,1.126~1.576,P<0.05)。多因素分析结果显示:肿瘤位于胃上区、中区、全胃、残胃,肿瘤直径≥5 cm,病理学分期为Ⅱ~Ⅳ期,浸润深度为T2~T4期,淋巴结转移为N1~N3期,脉管癌栓阳性,神经浸润阳性是影响胃癌患者预后的独立危险因素(HR=1.087,1.234,2.663,1.174,1.136,1.254,1.272,95%可信区间:1.008~1.172,1.063~1.432,2.292~3.095,1.035~1.332,1.044~1.236,1.064~1.501,1.066~1.516,P<0.05)。509例神经浸润阳性的胃癌患者5年生存率为49.1%,1 292例神经浸润阴性的胃癌患者为60.7%,两者生存情况比较,差异有统计学意义(x2=11.270, P<0.05)。383例神经浸润和脉管癌栓均为阳性的胃癌患者5年生存率为41.1%,126例神经浸润阳性及脉管癌栓阴性的胃癌患者为77.1%,437例神经浸润阴性及脉管癌栓阳性的胃癌患者为49.1%,855例 神经浸润和脉管癌栓均为阴性的胃癌患者为92.1%,4者5年生存情况比较,差异有统计学意义(x2=244.368,P<0.05)。
    结论:神经浸润是胃癌患者预后的高危因素,可作为评价胃癌患者术后预后的重要指标。

     

    Abstract: Objective:To investigate the relationship between perineural invasion and clinicopathological factors of gastric cancer or prognosis of patients.
    Methods:The retrospective casecontrol study was conducted. The clinicopathological data of 1 801 patients with gastric cancer who were admitted to the Affiliated Tumor Hospital of Fujian Medical University between March 1999 and November 2015 were collected. All the patients received surgery in order to the radical resection of gastric cancer, and total gastrectomy or twothirds and above of gastrectomy and D2 lymph node dissection were performed. Patients with preoperative stage III of clinical staging underwent neoadjuvant chemotherapy. Patients with T3-T4 of histopathologic stage, T1-T2 of positive lymph nodes and T2N0 of high risk factors (low differentiated tumor, lymphovascular invasion, perineural invasion and age <50 years) underwent postoperative chemotherapy. Observation indicators: (1) treatment situations; (2) pathological characteristics; (3) followup results; (4) prognostic factors. Followup using outpatient examination and telephone interview was performed once within 1 month postoperatively, once every 3 months within 2 years postoperatively and once every 6 months from 3 to 5 years postoperatively up to February 2016. Followup included inquiry, physical examination, routine blood test, biochemical test, carcinoembryonic antigen (CEA), CA199, color Doppler ultrasound or computed tomography (CT) and endoscopy. Measurement data with normal distribution were represented as ±s and comparison between groups was analyzed using the t test. Measurement data with skewed distribution were described as M (range). Ordinal data was analyzed by the nonparametric test. The univariate analysis and multivariate analysis were done using the COX regression model. The hazard ratio (HR) and 95% confidence interval (CI) were calculated. The survival curve and survival analysis were respectively drawn and done by the KaplanMeier method and Logrank test.
    Result: (1) Treatment situations: all the 1 801 patients underwent traditional open surgery, including 1 570 undergoing radical resection and 231 undergoing palliative surgery. Of 1 801 patients, 1 029 received total gastrectomy, 540 received distal gastrectomy, 201 received extended gastrectomy and 31 received resection of residual stomach. Operation time, volume of intraoperative blood loss, number of lymph node dissected and duration of hospital stay were (173±40)minutes, (224±91)mL, 30±13 and (15±9)days, respectively. Of 1 801 patients, 79 underwent preoperative neoadjuvant chemotherapy and 906 underwent postoperative adjuvant chemotherapy. (2) Pathological characteristics: results of pathological examinations of 1 801 patients showed that 509 had positive perineural invasion and 1 292 had negative perineural invasion. Tumors located in the upper region, middle region and lower region of stomach, whole stomach and stump stomach were respectively detected in 173, 189, 123, 12, 12 patients with positive perineural invasion and 395, 417, 428, 29, 23 patients with negative perineural invasion. Type Ⅰ, Ⅱ, Ⅲ and Ⅳ of Borrmann type were respectively detected in 13, 213, 244, 39 patients with positive perineural invasion and 92, 511, 629, 60 patients with negative perineural invasion. The good and poor tumor differentiations and tumor diameter <5 cm and ≥5 cm were respectively detected in 172, 337, 244, 265 patients with positive perineural invasion and 536, 756, 833, 459 patients with negative perineural invasion. Stage Ⅰ, Ⅱ, Ⅲ, Ⅳ of histopathologic stage, T1, T2, T3, T4 of invasive depth, N0, N1, N2, N3 of lymph node metastasis and positive and negative lymphovascular invasion were respectively detected in 27, 54, 346, 82, 17, 24, 26, 442, 77, 84, 109, 239, 383, 126 patients with positive perineural invasion and 263, 283, 623, 123, 188, 169, 289, 646, 409, 219, 312, 352, 437, 855 patients with negative perineural invasion, with statistically significant differences in above indexes between positive and negative perineural invasion patients (x2=14.142, Z=-2.098, 〖HT2.〗〖HT5”〗x2=9.061, 41.536, Z=-10.389, -13.824, -8.638, x2=252.624, P<0.05). (3) Followup results: 1 629 patients were followed up for 1.0-99.0 months, with a median time of 37.3 months. The 5year overall survival rate was 58.5%. (4) Prognostic factors: results of univariate analysis showed that tumor location, Borrmann type, degree of tumor differentiation, tumor diameter, histopathologic stage, invasive depth, lymph node metastasis, lymphovascular invasion and perineural invasion were factors affecting prognosis of patients with gastric cancer (HR=1.209, 1.303, 1.496, 2.303, 3.368, 2.057, 1.812, 2.013, 1.332, 95% CI: 1.123-1.301, 1.171-1.449, 1.290-1.736, 2.001-2.649, 3.012-3.767, 1.856-2.279, 1.694-1.939, 1.749-2.317, 1.126-1.576, P<0.05). Results of multivariate analysis showed that tumors located in the upper and middle of stomach, whole stomach and stump stomach, tumor diameter ≥5 cm, stage Ⅱ-Ⅳ of histopathologic stage, T2-T4 of invasive depth, N1-N3 of lymph node metastasis, positive lymphovascular invasion and positive perineural invasion were independent risk factors affecting prognosis of patients with gastric cancer (HR=1.087, 1.234, 2.663, 1.174, 1.136, 1.254, 1.272, 95% CI: 1.008-1.172, 1.063-1.432, 2.292-3.095, 1.035-1.332, 1.044-1.236, 1.064-1.501, 1.066-1.516, P<0.05). The 5year survival rate was 49.1% in 509 patients with positive perineural invasion and 60.7% in 1 292 patients with negative perineural invasion, respectively, with a statistically significant difference (x2=11.270, P<0.05). The 5year overall survival rate was 41.1% in 383 patients with positive perineural invasion and lymphovascular invasion, 77.1% in 126 patients with positive perineural invasion and negative lymphovascular invasion, 49.1% in 437 patients with negative perineural invasion and positive lymphovascular invasion and 92.1% in 855 patients with negative perineural invasion and lymphovascular invasion, respectively, with a statistically significant difference (x2=244.368, P<0.05).
    Conclusion: Perineural invasion is a high risk factor affecting prognosis of patients with gastric cancer, and it may be useful in evaluating prognosis of patients with gastric cancer.

     

/

返回文章
返回